Company intelligence / Profile preview

Broadview Ventures

Boston, Massachusetts, United Statesbroadviewventures.org ↗

Ownership: Private
Employees: ~50
Development stage: Clinical

Overview

Broadview Ventures is a mission-driven investment organization focused on accelerating the development of promising technologies for cardiovascular disease and stroke. Their portfolio companies have touched the lives of more than 483,000 patients as of 2023[4].

Therapeutic areas: CardiovascularNeurology
Industry: Investors

Drug pipeline

1 asset

OKL-1111

Clinical

Indications: Intracerebral hemorrhage

Partnerships

Massachusetts General Hospital (MGH)Technical University of Munich (TUM)[1]

Beyond the preview

Go deeper on Broadview Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Broadview Ventures.

Explore the full profile